Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Revenue
€ 700,235
▲ 37% vs 2024
Profit
Caution€ -1.7 million
▲ 19% vs 2024
Debts
Normal€ 4.8 million
▲ 8% vs 2024
BioKuris from Herstal, company number BE0769454379, closed financial year 2025 with a result of € -1.7 million after tax. For that financial year BioKuris recorded revenue of € 700,235 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € -2.1 million to € -1.7 million. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 28, 2026.
What happened at BioKuris?
What happened at BioKuris in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- INNODE SA stepped down as director. NBB
- SAPRAXIS SA stepped down as director. NBB
- Salvatore MODICA stepped down as director. NBB
- CEMAVI SARL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.7 million. Source: NBB ↗
- KitoZyme SA stepped down as director. NBB
- SAPRAXIS SA became a director. NBB
- KitoZyme SA became a director. NBB
In short
From € 2 million loss in 2022 to € 1.7 million loss in 2025.
A new publication or filing at BioKuris? We notify you, reason included.
Follow BioKurisNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by KitoZyme sa (76%) and Wallonie Entreprendre sa (7%).
Directors
According to the 2025 annual accounts
Managing director · represented by François BLONDEL
Owns 12.2% via KitoZyme sa
Also active at: Wishbone, KiOmed Pharma, ASKLEPIOS Capital
since 2021 · until 2027
Director · represented by Géry Lefebvre
Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International +228 more
since 2023 · until 2027
Salvatore MODICA
Director
since 2021 · until 2027
Director · represented by Pierre Desreumaux
since 2021 · until 2027
since 2023 · until 2026
Shareholders
KitoZyme sa · holding of INNODE SA
76%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de Milmort 680
4040 Herstal
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
GANDI-AS Domain name registrar - www.gandi.net, FR
Domain
Domain
biokuris.com
Registered
2021-05-26
Registrar
Gandi SAS
Expires
2026-05-26
Website info
Features
Security
Network
Details
- Company number
- 0769.454.379
- VAT number
- BE 0769.454.379
- Registered office
- Rue de Milmort 680, 4040 Herstal
- Names & denominations
- BioKuris
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 June 2021
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied